Beta-blockers after acute coronary syndrome: insights across the ejection fraction spectrum
To evaluate the association between beta-blocker (BB) prescription and long-term all-cause mortality after acute coronary syndrome (ACS), and to assess whether this varies across the left ventricular ejection fraction (LVEF) spectrum. We analysed ACS patients from the retrospective multicentre CardioMining...